PREVIOUS
✖
CAR-T cell therapy
June 12 , 2021
1282 days
1571
0
- The clinical trials of Chimeric Antigen Receptor T-cell (CAR-T) therapy were conducted globally.
- It has shown promising results on end stage cancer patients, especially in patients of Acute Lymphocytic Leukemia.
- First CAR-T cell Therapy was done by IIT Bombay and cancer care in India.
- It was done at Bone Marrow Transplant unit of Tata Memorial Centre in Mumbai.
- CAR-T cells were designed and manufactured at Bioscience and Bioengineering (BSBE) department, IIT Bombay.
- This was also supported by BIRAC-PACE scheme.
- Now, this therapy will undergo Phase I and II trial of their CAR-T product through National Biopharma Mission.
Leave a Reply
Your Comment is awaiting moderation.